Cargando…

1010. Effectiveness of Oral Antibiotics for Definitive Therapy of Gram-Positive Bloodstream Infections

BACKGROUND: Transition from intravenous (IV) to oral (PO) antibiotics is common practice in patients with Gram-positive bloodstream infections (GP-BSI); however, clinical data evaluating IV to PO switch options are lacking. The objective of this study was to examine effectiveness of PO antibiotics f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Roshdy, Danya, Quinn, Nick, Sebaaly, Jamie, Templin, Megan, Weinrib, David
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253518/ http://dx.doi.org/10.1093/ofid/ofy210.847

Ejemplares similares

Effectiveness of oral antibiotics for definitive therapy of non-Staphylococcal Gram-positive bacterial bloodstream infections
por: Quinn, Nicholas J., et al.
Publicado: (2019)

191. Oral Antibiotic Step-Down Therapy for Non-Staphylococcal Gram-Positive Bloodstream Infections
por: Gandhi, Kelvin, et al.
Publicado: (2021)

Factors Associated with Mortality in Carbapenem-Resistant Enterobacteriaceae Bacteremia: Focus on Antibiotic Therapy
por: Pillinger, Kelly E, et al.
Publicado: (2017)

166. Comparison of Oral Fluoroquinolones to Alternative Oral Agents for Definitive Step-Down Therapy in Gram-Negative Bloodstream Infections
por: Cho, Christian Y, et al.
Publicado: (2019)

289. Impact of Clinician Specialty on the Use of Oral Antibiotic Therapy for Definitive Treatment of Uncomplicated Bloodstream Infections
por: Marcelin, Jasmine R, et al.
Publicado: (2020)

1815. Assessment of Therapy Duration for Non-Staphylococcal Gram-Positive Bloodstream Infections
por: Gould, Alyssa P, et al.
Publicado: (2022)

224. Clinical Relevance of Antibiotic Tolerance in Recurrent Gram-negative Bloodstream Infections
por: Parsons, Joshua B, et al.
Publicado: (2023)

1050. Oral Antibiotics for the Treatment of Gram-Negative Bloodstream Infections: Prescribing Practices and Outcomes at a Large Academic Medical Center
por: Claeys, Kimberly, et al.
Publicado: (2018)

1001. Evaluation of the Clinical Efficacy and Safety of Oral Antibiotic Therapy for Streptococcus spp. Bloodstream Infections
por: Kang, Amy, et al.
Publicado: (2018)

2174. Comparison of the Verigene® and the ePlex® Blood Culture Identification Panels for Gram-Positive and Gram-Negative Bloodstream Infections
por: Johnson, J Kristie, et al.
Publicado: (2019)

2308. The Prevalence of Antiseptic Tolerance Genes Among Gram-Positive Bloodstream Pathogens in Children
por: Sommer, Lauren, et al.
Publicado: (2018)

131. Duration of Therapy for the Treatment of Gram-Negative Bloodstream Infections
por: Shulder, Stephanie, et al.
Publicado: (2019)

1325. Inpatient Initiation of ART Improves Short-Term Mortality in People Living with HIV
por: Campbell, Jamie, et al.
Publicado: (2019)

82. Assessment of Clinical Outcomes and Antibiotic Prescribing Patterns Following Implementation of the GenMark ePlex(®) Blood Culture Identification Panel for Gram-positive Bloodstream Infections
por: Wein, Megan, et al.
Publicado: (2021)

1841. Incidence and Predictors of Complications in Gram Negative Bloodstream Infection
por: Mondal, Utpal, et al.
Publicado: (2022)

315. Oral Vs. Intravenous Antibiotic Treatment for Gram-Positive Prosthetic Joint Infections: A Retrospective Study
por: Coehlo, Alexandre, et al.
Publicado: (2018)

1010. Effective Management of HIV in Rural Georgia Using Telemedicine
por: Lawal, Folake J, et al.
Publicado: (2020)

Procalcitonin Levels in Gram-Positive, Gram-Negative, and Fungal Bloodstream Infections
por: Leli, Christian, et al.
Publicado: (2015)

205. Evaluating the Time to Oral Step-Down Therapy for Gram-Negative Bloodstream Infections Associated with a Genitourinary Source
por: Mulvey, Nicole, et al.
Publicado: (2021)

222. Bloodstream Infections by Gram(−) Bacteria in Kidney Transplant Patients: Risk Factors, Incidence and Outcome; Bloodstream Infections by Gram(−) Bacteria in Kidney Transplant Patients: Risk Factors, Incidence and Outcome
por: Tsikala Vafea, Maria, et al.
Publicado: (2019)

Bloodstream Infection and Gram-Negative Resistance: The Role for Newer Antibiotics
por: Waters, Jessica, et al.
Publicado: (2023)

Impact of specialty on the self-reported practice of using oral antibiotic therapy for definitive treatment of bloodstream infections
por: Marcelin, Jasmine R., et al.
Publicado: (2023)

1043. Evaluation of Early Clinical Failure Criteria for Gram-Negative Bloodstream Infections
por: Rac, Hana, et al.
Publicado: (2018)

143. Modification of Linezolid Restriction Criteria Reduces ICU Gram-positive Antibiotic Consumption
por: Boulos, John M, et al.
Publicado: (2020)

1843. Intravenous versus Partial Oral Antibiotic Therapy in the Treatment of Uncomplicated Bloodstream Infection due to Streptococcus species
por: Broermann, Lynn, et al.
Publicado: (2022)

Survey of infectious diseases providers reveals variability in duration of antibiotic therapy for the treatment of Gram-negative bloodstream infections
por: Thaden, Joshua T., et al.
Publicado: (2022)

254. Genomic diversity of Gram-negative Bacilli from Bloodstream Infections in Hospitalized Children
por: Blumenthal, Jennifer, et al.
Publicado: (2023)

1027. Earlier Is Better: Progress Toward Decreased Time to Optimal Therapy and Improved Antibiotic Stewardship for Gram-positive Bloodstream Infections Through Use of GenMark Dx ePlex system
por: White, Cameron, et al.
Publicado: (2021)

159. Comparing Clinical Cure and Patient Outcomes Between Intravenous Therapy and Intravenous (IV)-to-Oral (PO) Step-down Therapy for Treatment of Gram-Negative Bloodstream Infections
por: Williams, Kelsey, et al.
Publicado: (2019)

10,10-Dimethylanthrone
por: Fun, Hoong-Kun, et al.
Publicado: (2010)

59. Risk Factors for Recurrent Gram-Negative Bacterial Bloodstream Infections
por: Bock, Andrew J, et al.
Publicado: (2021)

113. Accuracy of the NHSN Central Line-Associated Bloodstream Infection (CLABSI) Definition
por: Hammadi, Ahmed Al, et al.
Publicado: (2018)

1797. Evaluation of Intravenous vs Oral Antibiotic Therapy at Discharge for the Treatment of Urinary Source Gram-Negative Bacteremia
por: Yan, Xuping, et al.
Publicado: (2022)

1814. External Validation of Precision Antibiotic Therapy for Enterococcal Bloodstream Infections
por: Lee, Tiffany, et al.
Publicado: (2018)

906. Impact of Accelerate Rapid Diagnostic Technology on Time to Optimal Antimicrobial Therapy in Gram Negative Bloodstream Infection
por: Jung, Hye Lim, et al.
Publicado: (2022)

Gram-Negative Polymicrobial Bloodstream Infections and Clinical Decision Making with a Microarray Testing System
por: Claeys, Kimberly, et al.
Publicado: (2017)

141. Use of Rapid Diagnostic Testing in Gram-negative Bloodstream Infections with and without Antimicrobial Stewardship
por: Claeys, Kimberly C, et al.
Publicado: (2019)

147. Non-Fermenting Gram-Negative Bloodstream Infection: A Multicenter Retrospective Cohort Study
por: Pascale, Renato, et al.
Publicado: (2019)

Determining the Risk of Antimicrobial Resistance in Common Gram-Positive and Gram-Negative Pathogens After Antibiotic Exposure
por: Hudson, Nicholas, et al.
Publicado: (2015)

1022. Is it Time to Re-Evaluate Oral Β-Lactam Antibiotics for Step-Down Therapy of Uncomplicated Gram-Negative Bacteremia?
por: McAlister, Michael, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_1skb8ou2qdi47rlp8bbl7rbn7f